Breast biopsy device market is driven by factors like increasing level of awareness for breast cancer, growing number of screening programs, increase in ageing female population and technological advances in the breast imaging equipment. Furthermore, governments of emerging economies are actively initiating public awareness programs for diagnosing and treating breast cancers. However, the market growth of breast biopsy device is expected to encounter growth challenges due to the lack of competent professionals, significant costs and risk of infection. Nevertheless, the unexplored areas across the globe and increasing awareness about the disorder is offering lucrative opportunities to breast biopsy device industry.
Download Free Sample - https://www.millioninsights.com/industry-reports/breast-biopsy-device-market/request-sample
Breast biopsy devices market is categorized on the basis of product, technique, application, end user and geography. On the basis of product, the market is divided into needle-based biopsy instruments, procedure trays, localization wires and others. Needle based biopsy segment further comprises core-needle biopsy, fine-needle aspiration and vacuum-assisted core biopsy. Fine-needle segment is expected to hold larger market share of breast biopsy device due to increasing need for minimally invasive surgeries.
Based on technique, breast biopsy device industry is divided into MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy and others. Ultrasound biopsy segment is predicted to lead the industry of breast biopsy devices due to its growing acceptance.
In terms of application, breast biopsy device market is split into breast biopsy, colorectal biopsy, prostate biopsy, lung biopsy and others. Due to the growing awareness and increasing incidences of breast cancer, breast biopsy segment is expected to lead the market of breast biopsy devices in the near future. On the basis of end user, the market is classified into diagnostic and imaging centers, academic &research institutes and hospitals. Owing to the growing healthcare sector in the developing regions, hospital segment is expected to lead the industry of breast biopsy device in the coming years.
Geographically, breast biopsy device industry is segmented as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Asia Pacific is expected to lead the market of breast biopsy devices due to growing incidences of breast cancer and increasing ageing population of women in the region.
The prominent players in breast biopsy devices industry are Siemens AG, Argon Medical Devices Inc., Becton, Danaher Corporation, Sterylab S.R.L., Medtronic plc, Dickinson and Company, Cook Medical LLC., and Scion Medical Technologies LLC.
Browse full report with toc- https://www.millioninsights.com/industry-reports/breast-biopsy-device-market
Market Segment:
Breast Biopsy Devices Market By Test Type Outlook (Revenue, USD Million, 2013 - 2024)
• Needle breast biopsies
• Fine-needle aspiration
• Core-needle aspiration
• Vacuum-assisted core biopsy
• Open surgical biopsies
• Incisional breast biopsy
• Excisional breast biopsy
Breast Biopsy Devices Market By Product Outlook (Revenue, USD Million, 2013 - 2024)
• Biopsy needles
• Biopsy tables
• Localization wires
• Guidance systems
• Others
Breast Biopsy Devices Market By Guidance Type Outlook (Revenue, USD Million, 2013 - 2024)
• Ultrasound-guided
• Mammography-guided stereotactic
• Magnetic resonance-guided
Comments
Post a Comment